丁螺环酮与文拉法辛在广泛性焦虑症患者中的血药浓度及疗效的比较

Comparison of plasma concentration and efficacy of buspirone and Vin Rafa Sin in patients with generalized anxiety disorder

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2017, 44(5)
作者
作者单位

连云港市康复医院精神科 ;
连云港市第一人民医院检验科 ;

摘要
[摘要]探讨丁螺环酮与文拉法辛在广泛性焦虑症患者中的血药浓度及疗效。方法 本次研究选取2013年6月-2016年6月期间100例广泛性焦虑症患者作为对象。按照简单随机法将患者分为丁螺环酮组、文拉法辛组。比较两组患者HAMA、HAMD及SAS评分,用药剂量及血药浓度与治疗效果间的关系,治疗效果及不良反应发生情况。结果 两组患者经药物治疗后HAMA、HAMD及SAS评分均有下降(P<0.05);在治疗后2周、4周、6周,文拉法辛组患者HAMA、HAMD及SAS评分均低于丁螺环酮组(P<0.05)。丁螺环酮组患者血药浓度与HAMA评分无明显相关系(r=0.575,p>0.05),与HAMA减分率之间也无明显相关关系(r=-0.175,p>0.05)。文拉法辛组患者血药浓度与HAMA评分无明显相关系(r=0.582,p>0.05),与HAMA减分率之间也无明显相关关系(r=-0.164,p>0.05)。丁螺环酮组治疗有效率为90.00%,文拉法辛组患者治疗有效率为94.00%,两组患者治疗效果无显著性差异(p>0.05)。两组患者治疗后精神性焦虑及躯体性焦虑评分较治疗前明显降低(p<0.05);文拉法辛组患者治疗后精神性焦虑评分明显低于丁螺环酮组(p<0.05);文拉法辛组患者治疗后躯体性焦虑评分明显低于丁螺环酮组(p<0.05)。文拉法辛组患者共发生17例不良反应,发生率为34.00%,丁螺环酮组患者共发生13例不良反应,发生率为26.00%,两组患者治疗后不良反应发生率无明显差异(P>0.05)。结论 文拉法辛与丁螺环酮治疗广泛性焦虑症均有较好的治疗效果,不良反应较低,但是文拉法辛抗焦虑治疗的效果优于丁螺环酮。
Abstract
Abstract: Objective: To comparison of plasma concentration and efficacy of buspirone and Vin Rafa Sin in patients with generalized anxiety disorder. Methods: From June 2013 to June 2016, 100 cases of generalized anxiety disorder patients were studied. According to the simple random method were divided into Buspirone group and Venlafaxine group. The relationship between HAMA, HAMD and SAS score of two groups, the relationship between the dosage and the concentration of the drug and the therapeutic effect were compared between the two groups. Results: The HAMA, HAMD and SAS scores of the two groups were decreased after treatment (P<0.05), and the HAMA, HAMD and SAS scores of venlafaxine group were lower than those of buspirone group (P<0.05) at the end of the 2 week, the 4 week and the third week after treatment. There was no significant correlation between serum concentration and HAMA score (r=0.575, p>0.05), and there was no significant correlation between p>0.05 and HAMA score (r=-0.175). There was no significant correlation between the serum concentration of venlafaxine group and HAMA score (r=0.582, p>0.05), and there was no significant correlation between the p>0.05 and the HAMA score (r=-0.164). The effective rate of buspirone group was 90%, the effective rate of venlafaxine group was 94%, and there was no significant difference between the two groups (p>0.05). Two groups of patients after treatment of anxiety and somatic anxiety spirit was lower than that before treatment (p<0.05); venlafaxine group after treatment in patients with mental anxiety score was significantly lower than that of buspirone group (p<0.05); venlafaxine group after treatment in patients with somatic anxiety score was significantly lower than that of buspirone group (p<0.05). Buspirone group of patients with 17 cases of adverse reactions, the incidence rate was 34%, patients with venlafaxine group with 13 cases of adverse reactions, the incidence rate was 26%, two groups of patients after treatment, the incidence of adverse reactions was no significant difference (P>0.05). Conclusion: Venlafaxine and buspirone in the treatment of generalized anxiety disorder have a better therapeutic effect, adverse reactions are lower, but the effect of venlafaxine is better than that of buspirone.
关键词
关键词:丁螺环酮;文拉法辛;广泛性焦虑症;血药浓度;治疗效果
KeyWord
Keywords: Buspirone; venlafaxine; Generalized anxiety disorder; Plasma concentration; Therapeutic effect
基金项目
页码 804-806
  • 参考文献
  • 相关文献
  • 引用本文

马建英*,杜瑾,张婷婷,张晨曦. 丁螺环酮与文拉法辛在广泛性焦虑症患者中的血药浓度及疗效的比较 [J]. 国际精神病学杂志. 2017; 44; (5). 804 - 806.

  • 文献评论

相关学者

相关机构